T1	Intervention 883 998	continue receiving CFC albuterol or to be switched to receive HFA albuterol in a yearlong safety and efficacy trial
T2	Intervention 1049 1179	12 weeks of the yearlong trial between patients who had remained on CFC albuterol and those who had been switched to HFA albuterol
